Rezolute (RZLT) Enterprise Value Growth (1y) (2011 - 2026)
Rezolute (RZLT) Enterprise Value Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Rezolute | 31,153.77 | 31,153.77 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -38.36% |
| Dec 31, 2025 | -37.71% |
| Sep 30, 2025 | -40.57% |
| Jun 30, 2025 | -32.30% |
| Mar 31, 2025 | -8.60% |
| Dec 31, 2024 | -4.25% |
| Sep 30, 2024 | -9.59% |
| Jun 30, 2024 | -24.51% |
| Mar 31, 2024 | 22.32% |
| Dec 31, 2023 | 36.90% |
| Sep 30, 2023 | 35.98% |
| Jun 30, 2023 | 32.25% |
| Mar 31, 2023 | -62.45% |
| Dec 31, 2022 | -89.59% |
| Sep 30, 2022 | -313.82% |
| Jun 30, 2022 | -266.43% |
| Mar 31, 2022 | -98.24% |
| Dec 31, 2021 | -105.86% |
| Sep 30, 2021 | -482.32% |
| Jun 30, 2021 | 46.97% |